Stimulus induced CGRP release could be repressed by the 5-HT1B/D agonist sumatriptan [19], which is used in acute migraine treatment, and furthermore by botulinum toxin type A [20] and topiramate [21], two substances proved to be effective in migraine prophylaxis. The gene discussed is HTR1B; the disease is migraine disorder.